4D Molecular Therapeutics Inc (FDMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 60,241 | 48,555 | 77,159 | 133,526 | 149,336 |
| Marketable Securities | 342,414 | 256,508 | 216,066 | 187,911 | 275,541 |
| TOTAL | $413,134 | $312,377 | $303,287 | $332,566 | $434,932 |
| Non-Current Assets | |||||
| PPE Net | 14,867 | 16,153 | 17,505 | 18,745 | 19,534 |
| Investments And Advances | 111,379 | 67,165 | 123,806 | 137,004 | 80,583 |
| Other Non-Current Assets | 27,331 | 28,287 | 29,039 | 27,414 | 25,335 |
| TOTAL | $153,577 | $111,605 | $170,350 | $183,163 | $125,452 |
| Total Assets | $566,711 | $423,982 | $473,637 | $515,729 | $560,384 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,159 | 6,863 | 8,700 | 4,151 | 4,386 |
| Accrued Expenses | 26,874 | 24,189 | 19,190 | 16,203 | 18,869 |
| TOTAL | $43,985 | $37,107 | $34,677 | $26,899 | $29,149 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 360 | 360 | 1,066 | 866 | 257 |
| Other Non-Current Liabilities | 16,317 | 17,057 | 17,851 | 18,673 | 19,572 |
| TOTAL | $17,062 | $17,892 | $18,070 | $19,107 | $20,629 |
| Total Liabilities | $61,047 | $54,999 | $52,747 | $46,006 | $49,778 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,051 | 57,135 | 46,702 | 46,325 | 46,302 |
| Common Shares | 6 | 5 | 5 | 5 | 5 |
| Retained earnings | -716,304 | -735,701 | -678,825 | -624,167 | -576,195 |
| Other shareholders' equity | 727 | 671 | 337 | 332 | 229 |
| TOTAL | $505,664 | $368,983 | $420,890 | $469,723 | $510,606 |
| Total Liabilities And Equity | $566,711 | $423,982 | $473,637 | $515,729 | $560,384 |